Nicotinell Tropical Fruit (Nicotine Polacrilex)

Nicotine polacrilex is a nicotine‑salt complex that releases nicotine slowly when placed against the oral mucosa. The nicotine binds to nicotinic acetylcholine receptors in the mouth, producing mild systemic absorption that mimics the nicotine levels from smoking, thereby easing withdrawal and reducing the urge to smoke.

The appropriate dose and frequency are determined by a healthcare professional based on the individual’s smoking habits, level of dependence, and treatment goals. Patients should follow the prescriber’s instructions and the product labeling for safe use.

The safety of nicotine polacrilex in pregnancy or while breastfeeding has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To request Nicotinell Tropical Fruit, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nicotinell Tropical Fruit delivers nicotine via a buccal formulation, offering a discreet, non‑smokable alternative that provides steady nicotine release. Compared with nicotine gum or patches, it may have a faster onset of action and can be useful for smokers who prefer a fruit‑flavored, chew‑type product, while still achieving comparable cessation outcomes.

Store the product at room temperature, below 25 °C, in its original packaging. Protect it from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout its shelf life.

The product is placed in the mouth and allowed to dissolve slowly against the buccal mucosa. Users should avoid swallowing the entire dose at once and follow the recommended frequency indicated on the label or by their healthcare provider.

Serious risks include allergic reactions such as rash, swelling of the throat or airway, and rare cases of anaphylaxis. Cardiovascular effects like chest pain or palpitations may also occur, especially in individuals with pre‑existing heart conditions. Prompt medical attention is required if any of these symptoms develop.

Individuals with known hypersensitivity to nicotine or any component of the formulation, children, and those using other nicotine‑containing products should avoid this therapy. Persons with uncontrolled cardiovascular disease should consult a physician before initiating treatment.